VEON LTD. (VEON)
MoU Marks Major Milestone Toward Enabling Ukrainians to Invest in Nasdaq-Listed Kyivstar
CAN FITE BIO (CANF)
Can-Fite Secures Japanese Patent Allowance for Namodenosons Anti-Obesity Technology
Beyond Air (XAIR)
Beyond Air® Reports Fourth Quarter and Full Year 2026 Financial Results and Provides Corporate Update
Avalo Therapeutics Inc. (AVTX)
Avalo Therapeutics to Join the Russell2000® and Russell 3000® Indexes
CAN FITE BIOPHARMA LTD (CANF)
Japanese Patent Allowance for Namodenosons Anti-Obesity Technology
VENU HOLDING CORP (VENU)
VENU CEO J.W. Roth Featured on The Business Digest Radio Show & Podcast
AXSOME THERAPEUTICS, INC. (AXSM)
Axsome Therapeutics Initiates FOCUS-3 Phase 3 Trial of Solriamfetol in Adolescents with Attention Deficit Hyperactivity Disorder (ADHD)
GLOBAL PHARMATECH, INC. (OTCM)
OTC Markets Group Welcomes Nevada King Gold Corp. to OTCQX
JADE BIOSCIENCES, INC. (JBIO)
Jade Biosciences Announces Appointment of Mark Eisner, M.D., M.P.H., to Board of Directors
KYIVSTAR GROUP LTD. (KYIV)
Kyivstar and Ukraine’s Securities Regulator Sign Memorandum to Advance Capital Markets Development and Expand Investment Access